<style face="normal" font="default" size="100%">The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy.</style>

Drupal-Bibcite

0<style face="normal" font="default" size="100%">The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy.</style>